{"id":22998,"date":"2023-10-27T12:00:00","date_gmt":"2023-10-27T12:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4250918_CN50918_0"},"modified":"2023-10-27T12:00:00","modified_gmt":"2023-10-27T12:00:00","slug":"peijia-medical-presents-early-clinical-findings-of-geminione-teer-device-at-tct-2023","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=22998","title":{"rendered":"Peijia Medical Presents Early Clinical Findings of GeminiOne\u00ae TEER Device at TCT 2023"},"content":{"rendered":"<br \/>\n<table name=\"logo_release\" border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2166853\/PEIJIA_Logo_Logo.jpg?p=medium600\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span class=\"legendSpanClass\">SUZHOU, <span class=\"xn-location\">China<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Oct. 27, 2023<\/span><\/span> \/PRNewswire\/ &#8212; Peijia Medical Limited (Peijia, (9996.HK)), a leading Chinese medical device player in transcatheter structural heart device and neurovascular device, presented its GeminiOne<sup>&reg;<\/sup> TEER technology, along with the early clinical experiences of the device at the 35<sup>th<\/sup> Transcatheter Cardiovascular Therapeutics (TCT) conference. The session was presented by, Dr. <span class=\"xn-person\">Saibal Kar<\/span>, MD, Program Director of Cardiology at Los Robles Regional Medical Center and Physician Director of Interventional Cardiology at HCA Healthcare.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<\/p><\/div>\n<p>&quot;GeminiOne<sup>&reg;<\/sup> definitely has a unique design\u2026the most important part of the design is the sliding groove which allows longer coaptation length and closed as a smaller implant,&quot; said Dr. <span class=\"xn-person\">Saibal Kar<\/span>, MD. &quot;The design of GeminiOne<sup>&reg;<\/sup> seems to address some of the MitraClip&#8217;s shortcomings and hopefully, that it can be available in the U.S. soon,&quot; commented Professor <span class=\"xn-person\">Clifford Kavinsky<\/span>, the session&#8217;s moderator.<\/p>\n<p>GeminiOne<sup>&reg;<\/sup> is a novel TEER device that is designed to allow a longer coaptation length and minimized SLDA with sustained reduction in mitral regurgitation (MR). The thirty-day results (35 cases) reported no death, major adverse events, or conversion to surgery. Postoperative echo measures showed that 100% of the 35 patients had significant improvements in MR and maintained MR severity at 1+ or below at 30 days.<\/p>\n<p>&quot;Right from the beginning, GeminiOne<sup>&reg;<\/sup>&nbsp;design focuses on simplified clinical procedure with better performance. We are very encouraged by the early clinical results, and also being confident about the clean IP position of that design<span id=\"spanHghlt6145\">,<\/span>&quot; said Dr.&nbsp;Yi Zhang, Chairman and CEO of Peijia. &quot;With its intuitive design and promising clinical performance, we believe it will be the pioneering product for Peijia&#8217;s global footprint.&quot;<\/p>\n<p>GeminiOne<sup>&reg; <\/sup>is currently undergoing a multi-center clinical study in <span class=\"xn-location\">China<\/span> with 20+ enrolling sites. The pivotal study is intended for the treatment of high risk, symptomatic degenerative mitral regurgitation patients. The early feasibility study in the U.S. is expected to commence in 2024.<\/p>\n<p><b>About the Company<\/b><\/p>\n<p>Peijia Medical (9996.HK) was established in 2012 and is headquartered in Suzhou, <span class=\"xn-location\">China<\/span>. Peijia Medical focuses on the high-growth interventional procedural medical device market in <span class=\"xn-location\">China<\/span>, and aims to become a world-renowned medical device platform that provides comprehensive treatment solutions for structural heart and neurovascular diseases. The Company now has two generations of TAVR systems and fifteen neurointerventional devices commercialized in <span class=\"xn-location\">China<\/span> and various innovative product candidates at different stage of development. For more information about Peijia, visit <span id=\"spanHghlted99\"><a href=\"https:\/\/www.peijiamedical.com\/about_8\/\" target=\"_blank\" rel=\"nofollow noopener\">peijiamedical.com\/about<\/a>.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SUZHOU, China, Oct. 27, 2023 \/PRNewswire\/ &#8212; Peijia Medical Limited (Peijia, (9996.HK)), a leading Chinese medical device player in transcatheter structural heart device and neurovascular device, presented its GeminiOne&reg; TEER technology, along with the early clinical experiences of the device at the 35th Transcatheter Cardiovascular Therapeutics (TCT) conference. The session was presented by, Dr. Saibal [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-22998","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Peijia Medical Presents Early Clinical Findings of GeminiOne\u00ae TEER Device at TCT 2023 - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=22998\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Peijia Medical Presents Early Clinical Findings of GeminiOne\u00ae TEER Device at TCT 2023 - My Blog\" \/>\n<meta property=\"og:description\" content=\"SUZHOU, China, Oct. 27, 2023 \/PRNewswire\/ &#8212; Peijia Medical Limited (Peijia, (9996.HK)), a leading Chinese medical device player in transcatheter structural heart device and neurovascular device, presented its GeminiOne&reg; TEER technology, along with the early clinical experiences of the device at the 35th Transcatheter Cardiovascular Therapeutics (TCT) conference. The session was presented by, Dr. Saibal [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=22998\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-27T12:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnasia.com\/media2\/2166853\/PEIJIA_Logo_Logo.jpg?p=medium600\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22998#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22998\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Peijia Medical Presents Early Clinical Findings of GeminiOne\u00ae TEER Device at TCT 2023\",\"datePublished\":\"2023-10-27T12:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22998\"},\"wordCount\":416,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22998#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2166853\\\/PEIJIA_Logo_Logo.jpg?p=medium600\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22998\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22998\",\"name\":\"Peijia Medical Presents Early Clinical Findings of GeminiOne\u00ae TEER Device at TCT 2023 - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22998#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22998#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2166853\\\/PEIJIA_Logo_Logo.jpg?p=medium600\",\"datePublished\":\"2023-10-27T12:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22998#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22998\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22998#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2166853\\\/PEIJIA_Logo_Logo.jpg?p=medium600\",\"contentUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2166853\\\/PEIJIA_Logo_Logo.jpg?p=medium600\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=22998#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Peijia Medical Presents Early Clinical Findings of GeminiOne\u00ae TEER Device at TCT 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Peijia Medical Presents Early Clinical Findings of GeminiOne\u00ae TEER Device at TCT 2023 - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=22998","og_locale":"en_US","og_type":"article","og_title":"Peijia Medical Presents Early Clinical Findings of GeminiOne\u00ae TEER Device at TCT 2023 - My Blog","og_description":"SUZHOU, China, Oct. 27, 2023 \/PRNewswire\/ &#8212; Peijia Medical Limited (Peijia, (9996.HK)), a leading Chinese medical device player in transcatheter structural heart device and neurovascular device, presented its GeminiOne&reg; TEER technology, along with the early clinical experiences of the device at the 35th Transcatheter Cardiovascular Therapeutics (TCT) conference. The session was presented by, Dr. Saibal [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=22998","og_site_name":"My Blog","article_published_time":"2023-10-27T12:00:00+00:00","og_image":[{"url":"https:\/\/mma.prnasia.com\/media2\/2166853\/PEIJIA_Logo_Logo.jpg?p=medium600","type":"","width":"","height":""}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=22998#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=22998"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Peijia Medical Presents Early Clinical Findings of GeminiOne\u00ae TEER Device at TCT 2023","datePublished":"2023-10-27T12:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=22998"},"wordCount":416,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=22998#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/2166853\/PEIJIA_Logo_Logo.jpg?p=medium600","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=22998","url":"https:\/\/transmediavictoria.net.au\/?p=22998","name":"Peijia Medical Presents Early Clinical Findings of GeminiOne\u00ae TEER Device at TCT 2023 - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=22998#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=22998#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/2166853\/PEIJIA_Logo_Logo.jpg?p=medium600","datePublished":"2023-10-27T12:00:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=22998#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=22998"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=22998#primaryimage","url":"https:\/\/mma.prnasia.com\/media2\/2166853\/PEIJIA_Logo_Logo.jpg?p=medium600","contentUrl":"https:\/\/mma.prnasia.com\/media2\/2166853\/PEIJIA_Logo_Logo.jpg?p=medium600"},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=22998#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Peijia Medical Presents Early Clinical Findings of GeminiOne\u00ae TEER Device at TCT 2023"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/22998","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22998"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/22998\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22998"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22998"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22998"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}